Showing 781-790 of 2254 results for "".
- Teens with Epilepsy Are More Likely to Discuss Suicide Onlinehttps://practicalneurology.com/news/teens-with-epilepsy-are-more-likely-to-discuss-suicide-online/2469098/Results of a study presented at the American Epilepsy Society Annual Meeting December 6-10, 2019 in Baltimore, MD show that teens with epilepsy are more than twice as likely as adults with the condition to talk about suicide online. The data suggests that teens are concerned with the unknown aspe
- Women with Epilepsy Are Less Likely to Breastfeed Their Newbornshttps://practicalneurology.com/news/women-with-epilepsy-are-less-likely-to-breastfeed-their-newborns/2469096/Findings from 2 clinical studies presented at the American Epilepsy Society Annual Meeting, December 6-10 in Baltimore, MD show that women with epilepsy are less likely to breastfeed their newborns than new mothers without epilepsy. Support from neurologists and lactation consultants, however, ca
- Database of Eye-Tracking Movements Could Aid Diagnosis and Treatmenthttps://practicalneurology.com/news/database-of-eye-tracking-movements-could-aid-diagnosis-and-treatment/2468784/Eye-tracking technology (Brain Health EyeQ; RightEye, Bethesda, MD) that captures data on people’s eye movements has been used to produce a database of 1 billion data points from 100,000 individuals. Data includes eye tracking measures of alignment, object tracking, depth perception, and dy
- FDA Provides Expanded Clearance for Device to Treat Migraine in Childrenhttps://practicalneurology.com/news/fda-provides-expanded-clearance-for-device-to-treat-migraine-in-children/2468822/The Food and Drug Administration (FDA) has granted new marketing clearance for a device that provides acute and preventive treatment of migraine to include children 12 years of age and older. The technology (sTMS; eNeura, Inc., Baltimore, MD) is a non-invasive device that uses single-puls
- Explanation for the New Brunswick Mystery Illness Proposed in New Articlehttps://practicalneurology.com/news/explanation-for-the-new-brunswick-mystery-illness-proposed-in-new-article/2474615/The cluster of cases initially identified as the New Brunswick neurological syndrome of unknown cause (NSUC) and thought to constitute a novel neurologic disorder is likely to be a combination of well-known and misdiagnosed disorders, according to results of a cross-sectional study published in J
- New Podcast on COVID-19 Pandemic for People With Parkinson Diseasehttps://practicalneurology.com/news/new-podcast-on-covid-19-pandemic-for-people-with-parkinson-disease/2469251/A limited podcast series by the Michael J. Fox Foundation (MJFF) for Parkinson's Research will begin Wednesday, May 6, 2020. The series is designed to help individuals with Parkinson disease (PD) and their caregivers and partners navigate their way through the COVID-19 pandemic.
- Diagnosis and Care Recommendations for Limb-Girdle Muscle Dystrophy 2I/R9 Presentedhttps://practicalneurology.com/news/diagnosis-and-care-recommendations-for-limb-girdle-muscle-dystrophy-2ir9-presented/2473813/Draft standard of care (SoC) guidelines for the diagnosis and management of people with limb-girdle muscle dystrophy 2I/R9 (LGMDR9) were presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference. According to the presenters of the draft SoC, the guidelines ar
- Over $500,000 Awarded for ALS and Mitochondrial Myopathies Researchhttps://practicalneurology.com/news/over-500000-awarded-for-als-and-mitochondrial-myopathies-research/2470938/The Muscular Dystrophy Association (MDA; Chicago, IL) has partnered with the French Muscular Dystrophy Association (AFM-Téléthon; Evry, France) to award a total of $510,000 in grant funding across 2 research projects. The grant funding is intended to accelerate the development of tr
- Muscular Dystrophy Association Launches Initiative to Support the Development of Treatments for Ultra-Rare Neuromuscular Diseaseshttps://practicalneurology.com/news/muscular-dystrophy-association-launches-initiative-to-support-the-development-of-treatments-for-ultra-rare-neuromuscular-diseases/2470571/The Muscular Dystrophy Association (MDA) announced the launch of the MDA Kickstart Program, an initiative to advance the development of treatments for ultra-rare neuromuscular diseases. The first project under the MDA Kickstart Program will focus on the development of a gene therapy for a rare fo
- Muscular Dystrophy Association Applauds Landmark Proposal on Accessible Air Travelhttps://practicalneurology.com/news/muscular-dystrophy-association-applauds-landmark-proposal-on-accessible-air-travel/2470417/The Muscular Dystrophy Association (MDA) celebrates a significant milestone in air travel accessibility for individuals with disabilities related to a proposal aimed at enhancing the safety, rights, and dignity of air travelers with disabilities made by the Biden Administration and the US Departm